H&B France

H&B France is a biotechnology company based in Paris that specializes in the development of cell therapies using mesenchymal stem cells (MSCs) derived from the umbilical cord and placenta. Founded in 2015 as a subsidiary of the Health & Biotech Group, the company leverages patented technologies to produce clinical-grade stem cells and their derivatives. Its primary therapeutic focus is on treating vascular ischemia, supported by a foundation of extensive pre-clinical and clinical research from its parent organization. H&B France is actively involved in establishing manufacturing capacities for clinical batches and pursuing academic partnerships to expand its research programs. The company aims to advance regenerative medicine through innovative stem cell applications.